Wachtlin J, Khaireddin R, Hoffmann F
Augenklinik, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin.
Ophthalmologe. 2003 Dec;100(12):1021-30. doi: 10.1007/s00347-003-0934-8.
The demand for matched corneal grafts has risen rapidly over the last years. One reason for this is the change in the judgement of the value of tissue and especially HLA typing for prevention of an immune reaction in perforating corneal transplantation. Besides HLA or major antigens, there are other immunologically relevant tissue surface molecules such as the non-MHC antigens of which blood groups and minor antigens are the most important. With regard to effective cost-benefit and waiting time-benefit analyses, differentiated matching strategies are needed to assure optimized utilization and allocation of the still unsatisfactory number of available corneal grafts. With special matching strategies, such as the calculation of the individual waiting time, the consideration of split, non-MHC and HLA antigens, additional HLA loci as well as so-called "permissible" and "taboo" mismatches, much more has to be taken into account in the future than just the numerical correspondence of HLA antigens. This will make it possible to turn from a pure numerical approach to a functional matching strategy. This review summarizes the discussion and different matching strategies, possibilities and limitations of HLA and tissue typing in perforating corneal transplantation.
在过去几年中,对匹配角膜移植片的需求迅速增加。原因之一是对组织价值的判断发生了变化,尤其是在穿透性角膜移植中预防免疫反应的 HLA 分型。除了 HLA 或主要抗原外,还有其他与免疫相关的组织表面分子,如非 MHC 抗原,其中血型和次要抗原最为重要。关于有效的成本效益和等待时间效益分析,需要采用差异化的匹配策略,以确保对数量仍然不足的可用角膜移植片进行优化利用和分配。通过特殊的匹配策略,如计算个体等待时间、考虑分割、非 MHC 和 HLA 抗原、额外的 HLA 位点以及所谓的“允许”和“禁忌”错配,未来需要考虑的因素将远不止 HLA 抗原的数字对应。这将使从纯粹的数字方法转向功能匹配策略成为可能。本文综述了穿透性角膜移植中 HLA 和组织分型的讨论、不同匹配策略、可能性和局限性。